BindingDB logo
myBDB logout

Your request to link to MMDB for Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,M535I,I543V,L552P,A560V,V571A,I573V,L579M]

MMDB Description
7878Hiv-1 Protease Complexed With a Tripeptide Inhibitor
73437Hiv-1 Protease in Complex With Sdz283-910
73438Crystallographic Analysis of Human Immunodeficiency Virus 1 Protease With an Analog of the Conserved Ca-p2 Substrate: Interactions With Frequently Occurring Glutamic Acid Residue at P2' Position of Substrates
8033G48h Mutant of Hiv-1 Protease in Complex With a Peptidic Inhibitor U-89360e
158Hydroxyethylene Isostere Inhibitors of Human Immunodeficiency Virus-1 Protease: Structure-activity Analysis Using Enzyme Kinetics, X-ray Crystallography, and Infected T-cell Assays
6331Hiv-1 Protease in Complex With the Cyclic Sulfamide Inhibitor Aha006
6457Hiv-1 Protease in Complex With the Cyclic Urea Inhibitor Aha001
7498Active-site Mobility in Human Immunodeficiency Virus Type 1 Protease as Demonstrated by Crystal Structure of A28s Mutant
12513Counteracting Hiv-1 Protease Drug Resistance: Structural Analysis of Mutant Proteases Complexed With Xv638 and Sd146, Cyclic Urea Amides With Broad Specificities
12526Hiv-1 Protease (I84v) Complexed With Xv638 of Dupont Pharmaceuticals
4873Hiv-1 Protease-dmp323 Complex in Solution, NMR, 28 Structures
4872Hiv-1 Protease-dmp323 Complex in Solution, NMR Minimized Average Structure
12528Hiv-1 Protease (V82fi84v) Double Mutant Complexed With Xv638 of Dupont Pharmaceuticals
12529Hiv-1 Protease (V82fi84v) Double Mutant Complexed With Sd146 of Dupont Pharmaceuticals
14951Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop
14952Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop
14953Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop
14954Alternate Binding Site for the P1-p3 Group of a Class of Potent Hiv-1 Protease Inhibitors as a Result of Concerted Structural Change in 80's Loop
19717Hiv-1 Protease in Complex With the Inhibitor Bea435
19718Hiv-1 Protease in Complex With the Inhibitor Bea425
19719Hiv-1 Protease in Complex With the Inhibitor Msl370
11409Hiv-1 Protease V82fi84v Double Mutanttipranavir Complex
11395Hiv-1 Protease Triple Mutanttipranavir Complex
4447Hiv-1 Protease in Complex With a Difluoroketone Containing Inhibitor A79285
6563Structure of Hiv-1 Protease Complex
73558Structural and Kinetic Analysis of Drug Resistant Mutants of Hiv-1 Protease
19722Hiv-1 Protease in Complex With the Inhibitor Bea322
19723Hiv-1 Protease in Complex With the Inhibitor Bea369
19724Hiv-1 Protease in Complex With the Inhibitor Bea388
19725Hiv-1 Protease in Complex With the Inhibitor Bea403
19726Hiv-1 Protease in Complex With the Inhibitor Bea409
19727Hiv-1 Protease in Complex With the Inhibitor Bea428
19728Hiv-1 Protease in Complex With the Inhibitor Msa367
15090Crystal Structure of an in Vivo Hiv-1 Protease Mutant in Complex With Saquinavir: Insights Into the Mechanisms of Drug Resistance
73595Structural Implications of Drug Resistant Mutants of Hiv-1 Protease: High Resolution Crystal Structures of the Mutant Proteasesubstrate Analog Complexes
73608Crystal Structure of the Complex of Hiv-1 Protease With a Peptidomimetic Inhibitor
16449Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047
16387Crystal Structure of Hiv-1 Protease in Complex With Inhibitor, Aha024
5732Hiv-1 Protease Mutant With VAL 82 Replaced by ASP (V82d) Complexed With U89360e (Inhibitor)
5733Hiv-1 Protease Mutant With VAL 82 Replaced by ASN (V82n) Complexed With U89360e (Inhibitor)
5734Hiv-1 Protease (Wild Type) Complexed With U89360e (Inhibitor)
3498a Check on Rational Drug Design. Crystal Structure of a Complex of Hiv-1 Protease With a Novel Gamma-turn Mimetic
76639The Crystal Structures at 2.2 Angstroms Resolution of Hydroxyethylene-based Inhibitors Bound to Human Immunodeficiency Virus Type 1 Protease Show That the Inhibitors ARE Present in Two Distinct Orientations
73641The Crystal Structures at 2.2 Angstroms Resolution of Hydroxyethylene-based Inhibitors Bound to Human Immunodeficiency Virus Type 1 Protease Show That the Inhibitors ARE Present in Two Distinct Orientations
56338The Three-dimensional Structure of the Aspartyl Protease From the Hiv-1 Isolate BRU
3495Comparative Analysis of the X-ray Structures of Hiv-1 and Hiv-2 Proteases in Complex With CGP 53820, a Novel Pseudosymmetric Inhibitor
73646Crystal Structure of a Complex of Hiv-1 Protease With a Dihydroethylene-containing Inhibitor: Comparisons With Molecular Modeling
1233Inhibition of Human Immunodeficiency Virus-1 Protease by a C2- Symmetric Phosphinate Synthesis and Crystallographic Analysis
5809Hiv-1 Protease Triple Mutantu103265 Complex
1237Rational Design, Synthesis and Crystallographic Analysis of a Hydroxyethylene-based Hiv-1 Protease Inhibitor Containing a Heterocyclic P1'-p2' Amide Bond Isostere
1239Crystal Structure of Hiv-1 Protease in Complex With Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme
4428Hiv-1 Protease Complexed With the Inhibitor Kni-272
4292Crystal Structure at 1.9 Angstroms Resolution of Human Immunodeficiency Virus (Hiv) II Protease Complexed With L- 735,524, an Orally Bioavailable Inhibitor of the HIV Proteases
1260X-ray Crystallographic Studies of a Series of Penicillin- Derived Asymmetric Inhibitors of Hiv-1 Protease
1261X-ray Crystallographic Studies of a Series of Penicillin- Derived Asymmetric Inhibitors of Hiv-1 Protease
1262X-ray Crystallographic Studies of a Series of Penicillin- Derived Asymmetric Inhibitors of Hiv-1 Protease
8945Nonpeptide Cyclic Cyanoguanidines as HIV Protease Inhibitors
1281Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease
1282Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease
1283Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease
1284Influence of Stereochemistry on Activity and Binding Modes for C2 Symmetry-based Diol Inhibitors of Hiv-1 Protease
72319Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors
1289Structural Basis of Drug Resistance for the V82a Mutant of Hiv-1 Protease: Backbone Flexibility and Subsite Repacking
9831Molecular Recognition of Cyclic Urea HIV Protease Inhibitors
49549Hiv-1 Proteinase Complexed With RO 31-8959
7007Hiv-1 Protease Dimer Complexed With A-84538
49668Crystal Structure of Hiv-1 Protease Complexed With a Hydroxyethylamine Peptidomimetic Inhibitor
21361Inhibitor of HIV Protease With Unusual Binding Mode Potently Inhibiting Multi-resistant Protease Mutants
21362Inhibitor of HIV Protease With Unusual Binding Mode Potently Inhibiting Multi-resistant Protease Mutants
18417Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease
18418Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease
18419Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease
18420Lack of Synergy for Inhibitors Targeting a Multi-drug Resistant Hiv-1 Protease
50197Crystal Structure of the Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With an Ethylenamine Peptidomimetic Inhibitor Boc-phe-psi[ch2ch2nh]-phe-glu-phe-nh2
50201Hiv-1 Protease in Complex With an Ethyleneamine Inhibitor
7493Hiv-1 Mutant (I84v) Protease Complexed With Dmp450
7494Hiv-1 Mutant (I84v) Protease Complexed With Dmp323
7495Hiv-1 Mutant (V82f) Protease Complexed With Dmp323
7496Hiv-1 Mutant (V82f, I84v) Protease Complexed With Dmp323
24931Structure of HIV Protease (Mutant Q7K L33i L63i) Complexed With Kni- 577
24932Structure of HIV Protease (Mutant Q7K L33i L63i V82f I84v ) Complexed With Kni-577
24933The HIV Protease (Mutant Q7K L33i L63i) Complexed With Kni-764 (AN Inhibitor)
24934The HIV Protease (Mutant Q7K L33i L63i V82f I84v) Complexed With Kni- 764 (AN Inhibitor)
21013Crystal Structure of Hiv-1 Protease Complexed With Lopinavir
504621.03 a Structure of Hiv-1 Protease: Inhibitor Binding Inside and Outside the Active Site
26006Crystal Structure of Hiv-1 Protease-hup
21903Crystal Structure of Hiv-1 Protease Complexed With Ldc271
21904Crystal Structure of HIV Protease Complexed With Lgz479
50612Native Hiv-1 Proteinase
50613Hiv-1 Proteinase Mutant A71t, V82a
50614Hiv-1 Protease Complexed With an Inhibitor Lp-130
9068Viracept (R) (Nelfinavir Mesylate, Ag1343): a Potent Orally Bioavailable Inhibitor of Hiv-1 Protease
4836Hiv-1 Protease Dimer Complexed With A-98881
6661Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency
6662Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency
6663Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency
6664Hiv-1 Protease Inhibitors Wiih LOW Nanomolar Potency
32717Crystal Structure of the Complex of Resistant Strain of Hiv- 1 Protease(v82a Mutant) With Ritonavir
30822Crystal Structures of a Multidrug-resistant Hiv-1 Protease Reveal an Expanded Active Site Cavity
30824Crystal Structures of a Multidrug-resistant Hiv-1 Protease Reveal an Expanded Active Site Cavity
30832Crystal Structures of a Multidrug-resistant Hiv-1 Protease Reveal an Expanded Active Site Cavity
2155An Orally-bioavailable Hiv-1 Protease Inhibitor Containing an Imidazole-derived Peptide Bond Replacement. Crystallographic and Pharmacokinetic Analysis
27817Crystal Structures of HIV Protease V82a and L90m Mutants Reveal Changes in Indinavir Binding Site
27818Crystal Structures of HIV Protease V82a and L90m Mutants Reveal Changes in Indinavir Binding Site
29356Comparing the Accumulation of Active Site and Non-active Site Mutations in the Hiv-1 Protease
29357Comparing the Accumulation of Active Site and Non-active Site Mutations in the Hiv-1 Protease
34058Crystal Structure of Hiv-1 Protease Complexed With a Product of Autoproteolysis
33412The Structural and Thermodynamic Basis for the Binding of Tmc114, a Next-generation Hiv-1 Protease Inhibitor
33413Crystal Structure of Inhibitor Amprenavir in Complex With a Multi-drug Resistant Variant of Hiv-1 Protease (L63pv82ti84v)
29418Crystal Structure of HIV Protease Complexed With Arylsulfonamide Azacyclic Urea
5483HIV Triple Mutant Protease Complexed With Inhibitor Sb203386
34066Wide Open 1.3a Structure of a Multi-drug Resistant Hiv-1 Protease Represents a Novel Drug Target
74346Crystal Structure of a Hiv-1 Protease in Complex With Peptidomimetic Inhibitor Ki2-phe-glu-glu-nh2
57578Hiv-1 Protease Complex With U095438 [3-[1-(4-bromophenyl) Isobutyl]-4- Hydroxycoumarin
9368Hiv-1 Protease Complexed With the Inhibitor Hoebay 793 Hexagonal Form
9073Hiv-1 Protease Complexed With the Inhibitor Hoebay 793 Orthorhombic Form
31015Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor
31016Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor
34484Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor
30102Hiv-1 Protease in Complex With Fluoro Substituted Diol- Based C2-symmetric Inhibitor
30471Hiv-1 Protease in Complex With Asymmetric Inhibitor, Bea568
30472Hiv-1 Protease in Complex With Symmetric Inhibitor, Bea450
33692Hiv-1 Protease in Complex With Pyrrolidinmethanamine
33693Hiv-1 Protease in Complex With Amidhyroxysulfone
32957HIV Protease With Oximinoarylsulfonamide Bound
52200Crystal Structure of the Complex of Mutant Hiv-1 Protease (L63p, A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[r-ch(oh)ch2nh]-phe- Glu-phe-nh2
52209Crystal Structure of a Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[r-ch(oh)ch2nh]-phe-glu-phe-nh2
74482Crystal Structure of a Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[s-ch(oh)ch2nh]-phe-glu-phe-nh2
74485Crystal Structure of a Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor
33905HIV Protease With Inhibitor Ab-2
33190HIV Protease With Scripps Ab-3 Inhibitor
52289Crystal Structure of the Complex of Mutant Hiv-1 Protease (A71v, V82t, I84v) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe-psi[r-ch(oh)ch2nh]-phe-glu-phe-nh2
74491Crystal Structure of Complex of a Hydroxyethylamine Inhibitor With Hiv-1 Protease at 2.0a Resolution
74492Crystal Structure of Wild Type Hiv-1 Protease (Bru Isolate) With a Hydroxyethylamine Peptidomimetic Inhibitor Boc-phe- Psi[s-ch(oh)ch2nh]-phe-glu-phe-nh2
35560Crystal Structure of HIV Protease- Metallacarborane Complex
35165Synthesis and Activity of N-axyl Azacyclic Urea Hiv-1 Protease Inhibitors With High Potency Against Multiple Drug Resistant Viral Strains
37072Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog Ca-p2
86753Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog P1-p6
86754Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog P2-nc
37075Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Substrate Analog P6-pr
40657Structure of Hiv-1 Protease Bound to Atazanavir
52537Hiv-1 Protease Nl4-3 in Complex With Inhibitor, Tl-3
52538Hiv-1 Protease Nl4-3 1X Mutant
52539Hiv-1 Protease Nl4-3 3X Mutant in Complex With Inhibitor, Tl-3
52540Hiv-1 Protease Nl4-3 6X Mutant
42560Structure of Hiv-1 Protease Mutant Bound to Ritonavir
42561Structure of Hiv-1 Protease Mutant Bound to Indinavir
36187Structure of Hiv1 Protease and Akc4p_133a Complex
36188Structure of Hiv1 Protease and Hh1_173_3a Complex
9577Hiv-1 Protease-inhibitor Complex
9578Hiv-1 Protease-inhibitor Complex
9579Hiv-1 Protease-inhibitor Complex
9580Hiv-1 Protease-inhibitor Complex
9581Hiv-1 Protease-inhibitor Complex
36732Hiv-1 Protease in Complex With Inhibitor Aha455
44310P1' Extended Hiv-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-state Mimicking Scaffold
44311P1' Extended Hiv-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-state Mimicking Scaffold
44312P1' Extended Hiv-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-state Mimicking Scaffold
38235Hiv-1 Protease Mutant L90m Complexed With Inhibitor Tmc114
37729Crystal Structure of HIV Protease D545701 Bound With Gw0385
37730Wild Type HIV Protease Bound With Gw0385
43759Structural Analysis of Asymmetric Inhibitor Bound to the Hiv-1 Protease V82a Mutant
47124Structure of HIV Protease 6X Mutant in APO Form
47125Structure of HIV Protease Nl4-3 in an Unliganded State
47126Structure of HIV Protease 6X Mutant in Complex With Ab-2
58047Three-dimensional Structure of Aspartyl Protease From Human Immunodeficiency Virus Hiv-1
60050Crystal Structure of WT Hiv-1 Protease With Gs-8373
58951Hiv-1 Protease With Tmc-126
58952Hiv-1 Protease I84v, L90m With Tmc126
58953Hiv-1 Protease WT With Gs-8374
58954Hiv-1 Protease I84v, L90m With Gs-8374
41799Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Potent Non-peptide Inhibitor (Uic-94017)
45139Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Inhibitor Saquinavir
45140Crystal Structure Analysis of Hiv-1 Protease Mutant V82a With a Inhibitor Saquinavir
43491Crystal Structure of Hiv1 Protease in Situ Product Complex
43605Crystal Structure of Hiv-1 Protease (Q7k) in Complex With Atazanavir
43606Crystal Structure of Hiv-1 Protease (Q7k, I50v) in Complex With Tipranavir
43607Crystal Structure of Hiv-1 Protease (Trm Mutant) in Complex With Tipranavir
43608Crystal Structure of Hiv-1 Protease (Q7k) in Complex With Tipranavir
43609Crystal Structure of Hiv-1 Protease (Q7k) in Complex With Lopinavir
45722Crystal Structure of the Multi-drug Resistant Mutant Subtype B HIV Protease Complexed With Tl-3 Inhibitor
45723Crystal Structure of the Subtype B Wild Type HIV Protease Complexed With Tl-3 Inhibitor
47218APO Wild-type HIV Protease in the Open Conformation
46591Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i ) in Complex With Kni-10075
46592Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10033
63765Hiv-1 Protease in Complex With a Pyrrolidine-based Inhibitor
63769Hiv-1 Protease in Complex With a Amino Decorated Pyrrolidine-based Inhibitor
63770Hiv-1 Protease in Complex With a Carbamoyl Decorated Pyrrolidine-based Inhibitor
62669Hiv-1 PR Mutant in Complex With Nelfinavir
62673Hiv-1 PR Mutant in Complex With Nelfinavir
62674Hiv-1 PR Mutant in Complex With Nelfinavir
65163Hiv-1 PR Mutant in Complex With Nelfinavir
63915Hiv-1 Protease Mutant V82a With Potent Antiviral Inhibitor Grl-98065
65545The Influence of I47a Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir
65553Crystal Structure of Hiv-1 Protease Complexed With Pl-100
63777Hiv-1 Protease in Complex With a Multiple Decorated Pyrrolidine-based Inhibitor
63778Hiv-1 Protease in Complex With a Iodo Decorated Pyrrolidine- Based Inhibitor
63779Hiv-1 Protease in Complex With a Chloro Decorated Pyrrolidine-based Inhibitor
66402I84v Hiv-1 Protease Mutant in Complex With a Carbamoyl Decorated Pyrrolidine-based Inhibitor
66403I50v Hiv-1 Protease Mutant in Complex With a Carbamoyl Decorated Pyrrolidine-based Inhibitor
66404I84v Hiv-1 Protease in Complex With a Amino Decorated Pyrrolidine-based Inhibitor
66548I50v Hiv-1 Protease in Complex With an Amino Decorated Pyrrolidine- Based Inhibitor
4714Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl [4-hydroxy- 2oxo-6-[1-(phenylmethyl)propyl]-2h-pyran-3-yl] Methyl]phenyl]amino]- 3-oxo-propyl]carbamic Acid Tert-butyl Ester)
64505Two-carbon-elongated Hiv-1 Protease Inhibitors With a Tertiary-alcohol-containing Transition-state Mimic
64506Two-carbon-elongated Hiv-1 Protease Inhibitors With a Tertiary-alcohol-containing Transition-state Mimic
78684Hiv-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-state Mimic With Improved Cell-based Antiviral Activity
78685Hiv-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-state Mimic With Improved Cell-based Antiviral Activity
65219The Influence of I47a Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir
69386Hiv-1 Protease in Complex With a Dimethylallyl Decorated Pyrrolidine Based Inhibitor (Hexagonal Space Group)
61422Hiv-1 Protease Mutant I54v Complexed With Gem-diol-amine Intermediate Nlltqi
66440I84v Hiv-1 Protease in Complex With a Pyrrolidine Diester
66441Hiv-1 Protease in Complex With a Isobutyl Decorated Oligoamine
66442Hiv-1 Protease in Complex With a Benzyl Decorated Oligoamine
68388Hiv-1 Protease in Complex With a Three Armed Pyrrolidine Derivative
70361Hiv-1 Protease in Complex With a Dimethylallyl Decorated Pyrrolidine Based Inhibitor (Orthorombic Space Group)
64718Crystal Structure of Hiv-1 Mutant I54v and Inhibitor Saquina
64720Crystal Structure of Hiv-1 Mutant I54v and Inhibitor Darunavia
76414Crystal Structure of Inhibitor Saquinavir (Sqv) Complexed With the Multidrug Hiv-1 Protease Variant L63pv82ti84v
76415Crystal Structure of Nelfinavir (Nfv) Complexed With a Multidrug Variant (Act) (V82ti84v) of Hiv-1 Protease
72913HIV Protease Inhibitors With Pseudo-symmetric Cores
72914HIV Protease, Pseudo-symmetric Inhibitors
72915HIV Protease, Pseudo-symmetric Inhibitors
78436Crystal Structure of a Metallacarborane Inhibitor Bound to HIV Protease
80488Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10006
80811Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10074
80489Crystal Structure of Hiv-1 Protease (Q7k, L33i, L63i) in Complex With Kni-10265
80269HIV Protease With Fragment 4D9 Bound
80273HIV Protease (Pr) With Inhibitor Tl-3 and Fragment HIT 4D9 by Soaking
80274HIV Protease (Pr) With Inhibitor Tl-3 Bound, and Dmsos in EXO Site
80275HIV Protease (Pr) Dimer With Inhibitor Tl-3 Bound and Fragment 1F1 in the Outsidetop of Flap
80276HIV Protease (Pr) Dimer With Inhibitor Tl-3 Bound and Fragment 2F4 in the Outside/top of Flap
83066HIV Protease Complexed With Compound 10B
89829X-ray Snapshot of Hiv-1 Protease in Action: Observation of Tetrahedral Intermediate and ITS Sihb With Catalytic Aspartate
84435Crystal Structure of Hiv-1 Protease Mutant I54v With Antiviral Drug Amprenavir
84436Crystal Structure of Hiv-1 Protease Mutant L90m With Antiviral Drug Amprenavir
89684Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants
89685Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants
89686Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants
89529Mdr769 Hiv-1 Protease Complexed With Maca Hepta-peptide
89530Mdr769 Hiv-1 Protease Complexed With Rtrh Hepta-peptide
89531Mdr769 Hiv-1 Protease Complexed With Rhin Hepta-peptide
89532Mdr769 Hiv-1 Protease Complexed With Prrt Hepta-peptide
89533Mdr769 Hiv-1 Protease Complexed With Tfpr Hepta-peptide
89534Mdr769 Hiv-1 Protease Complexed With P1p6 Hepta-peptide
89535Mdr769 Hiv-1 Protease Complexed With Ncp1 Hepta-peptide
89536Mdr769 Hiv-1 Protease Complexed With P2nc Hepta-peptide
89537Mdr769 Hiv-1 Protease Complexed With Cap2 Hepta-peptide
58353X-ray Analysis of Hiv-1 Proteinase at 2.7 Angstroms Resolution Confirms Structural Homology Among Retroviral Enzymes
89695Crystal Structures of Multidrug-resistant Clinical Isolate 769 Hiv-1 Protease Variants
12235Structural Studies of HIV and FIV Proteases Complexed Withan Efficient Inhibitor of FIV PR
3200X-ray Crystal Structure of the HIV Protease Complex With L- 700,417, an Inhibitor With Pseudo C2 Symmetry
54778Crystallographic Analysis of a Complex Between Human Immunodeficiency Virus Type 1 Protease and Acetyl- Pepstatin at 2.0-angstroms Resolution
5757Hiv-1 Proteaseu101935 Complex
54880Design, Activity and 2.8 Angstroms Crystal Structure of a C2 Symmetric Inhibitor Complexed to Hiv-1 Protease